CEO Executive AssistantThe chief of staff title appears frequently in pharmaceutical organizations, but what the role actually entails varies significantly from one organization to the next. This guide provides a clear definition of what a chief of staff is in a pharmaceutical context, what distinguishes it from other executive support roles, and what characteristics define a high-performing version of this function.
Defining the Chief of Staff Role in Pharmaceutical & Biotech
In a pharmaceutical company, the chief of staff is a senior executive-level professional who operates as the primary organizational partner to the CEO. Their mandate is to create the operating conditions for effective executive leadership by managing the coordination, communication, and project infrastructure that the CEO cannot manage alone at scale.
The role is distinct from:
Executive assistant: The EA manages the CEO’s logistics and administrative functions. The chief of staff manages the CEO’s organizational impact and strategic execution. Both roles may exist simultaneously in larger pharmaceutical organizations, serving complementary but different functions.
Chief operating officer: The COO manages the day-to-day operational performance of the business. The chief of staff manages the CEO’s office as an operating unit and serves the CEO’s strategic priorities across the organization. In some pharmaceutical organizations these functions overlap, but they are conceptually distinct.
Business development or strategy roles: The chief of staff in a pharmaceutical company is not primarily responsible for generating new business or developing strategy. They are responsible for ensuring the CEO can execute the strategic agenda they have set.
Harvard Business Review on executive time provides a foundational analysis of the chief of staff role’s evolution from governmental origins to corporate application, noting its particular value in organizations facing rapid growth or complex stakeholder environments.
What the Chief of Staff Does in Pharmaceutical & Biotech
In a pharmaceutical organization, the chief of staff’s core mandate covers five domains:
Organizational coordination. Managing cross-functional alignment across the CEO’s priority initiatives. In pharmaceutical, this includes overseeing cross-functional executive initiative coordination between clinical development, regulatory affairs, medical affairs, and commercial leadership and coordinating regulatory submission preparation workflows and FDA and international agency communication management.
Governance and compliance support. Ensuring the CEO is prepared for all board, committee, and regulatory engagements and that obligations in these areas are tracked and met. This addresses tracking IND and NDA submission deadlines, clinical trial reporting obligations, and pharmacovigilance compliance calendars across active development programs.
Stakeholder relationship management. Maintaining the relationship infrastructure that keeps key external parties engaged and informed. In pharmaceutical, this includes managing investor relations communications, partnership negotiation support, and scientific advisory board coordination.
Information management. Filtering, synthesizing, and delivering the information the CEO needs to make decisions without consuming excessive time on data aggregation. This addresses managing clinical trial program oversight, regulatory submission timelines, and FDA agency relationship management simultaneously with strategic leadership obligations.
Executive project ownership. Taking end-to-end ownership of high-priority initiatives that do not fit within any existing department’s charter. This frees the CEO from serving as default project manager for every cross-functional endeavor.
What Makes a Chief of Staff Effective in Pharmaceutical & Biotech
Effectiveness in a pharmaceutical chief of staff role requires three things beyond general capability: sector literacy, earned trust, and clear scope definition.
Sector literacy means understanding the operational, regulatory, and relational context of pharmaceutical organizations well enough to anticipate needs, interpret signals, and navigate the environment without constant guidance.
Earned trust means the CEO has delegated meaningful authority to the chief of staff and is confident that decisions made and communications sent in their name accurately represent their judgment and standards.
Clear scope means both parties understand what is and is not within the chief of staff’s domain, eliminating the ambiguity that leads to either overreach or underutilization.
For the complete framework on defining and structuring this role in a pharmaceutical organization, see our pharma CEO support guide. For context on the broader CEO support ecosystem, see our guide to pharma time management.
Building This Function in Your Pharmaceutical & Biotech Organization: A Practical Framework
Understanding this aspect of CEO support in a pharmaceutical organization is valuable. Implementing it effectively requires a deliberate approach that addresses the specific operational demands of your context. The following framework translates the concepts covered above into concrete actions that pharmaceutical executives can take to build or improve their CEO support function.
Step 1: Conduct an Honest Audit of Your Current Time Allocation
Before making structural changes to your CEO support function, conduct an honest audit of where your time is actually going. Most pharmaceutical CEOs, when they track their weekly hours explicitly, discover that 30 to 45 percent of their time is consumed by coordination, communications, and administrative work that could be owned by a well-resourced support professional.
Specific time drains in pharmaceutical executive leadership to audit for: managing clinical trial program oversight, regulatory submission timelines, and FDA agency relationship management simultaneously with strategic leadership obligations, coordinating investor communications, partnership and licensing negotiations, and scientific advisory board management during key development milestones, and tracking IND and NDA submission deadlines, clinical trial reporting obligations, and pharmacovigilance compliance calendars across active development programs. Time you spend personally managing these functions is time you are not spending on the strategic leadership activities that only you can provide.
Document your findings in a simple format: function, estimated weekly hours, and whether CEO-level judgment is actually required. The documentation almost always reveals more delegatable work than the pharmaceutical CEO expected.
Step 2: Define Clear Ownership Before Delegating
The most common failure in CEO support relationships in pharmaceutical organizations is ambiguous ownership. Before delegating any function to a chief of staff or executive support professional, define explicitly: what they own, what decisions they can make independently, what requires CEO sign-off, and how they should escalate when uncertain.
In the pharmaceutical context, this clarity is especially important for preparing executive briefings for board meetings, investor presentations, and key regulatory agency interactions and overseeing cross-functional executive initiative coordination between clinical development, regulatory affairs, medical affairs, and commercial leadership, where the stakes of a mishandled situation are high and where the chief of staff needs to know precisely when to act independently versus when to involve the CEO.
Documenting these ownership parameters before the engagement begins, not after problems arise, is one of the most important investments a pharmaceutical CEO makes in the support relationship.
Step 3: Set Measurable Performance Standards From Day One
Effective pharmaceutical CEO support is measurable. The performance standards that matter most include: regulatory submission deadline tracking accuracy and advance preparation lead time before FDA and international agency filing windows, board and investor meeting preparation completion 48 hours before each session, scientific advisory board and key opinion leader communication response time and relationship follow-up completion rate, and clinical trial reporting and pharmacovigilance compliance deadline tracking accuracy across all active development programs. Establishing these standards at the outset of the support relationship creates accountability and provides a clear framework for the performance conversations that drive continuous improvement.
Performance conversations in a pharmaceutical chief of staff relationship should happen regularly, not just when problems arise. A 30-minute weekly alignment conversation and a monthly performance calibration are sufficient to keep the relationship on track and developing in the right direction.
Step 4: Ensure Access to the Right Tools and Systems
The pharmaceutical executive support function requires specific tools to operate effectively. The core technology stack typically includes Microsoft 365, Veeva Vault, Salesforce, Workday and the systems needed to manage regulatory submission management and clinical program coordination. Ensuring your chief of staff or executive support professional has appropriate access to these tools from day one is essential for fast time-to-productivity.
Restricting tool access to protect confidentiality is a false economy. A chief of staff who cannot access the systems they need to do their job operates with one hand tied behind their back. Establish appropriate access with proper confidentiality agreements in place from the first day.
Step 5: Invest in the 90-Day Onboarding Ramp
Even the most experienced pharmaceutical chief of staff requires 60 to 90 days to reach full productivity in a new CEO support relationship. The onboarding period involves context transfer that cannot be rushed: walk through your active development pipeline, key regulatory and investor relationships, and current submission and milestone calendar, introduce your chief of staff to your clinical development and regulatory affairs leads, medical affairs team, key investor contacts, and scientific advisory board members, establish communication protocols for regulatory submission deadlines, clinical trial results reporting, investor communications, and board matters, and transfer calendar ownership for board and committee meetings, regulatory agency interactions, investor events, and executive travel to clinical sites.
CEOs who invest in this ramp period with structured onboarding conversations, deliberate context sharing, and consistent feedback get dramatically better long-term results than those who expect full productivity in the first two weeks. The 90-day investment in onboarding pays dividends that compound over the entire duration of the relationship, which in strong CEO-chief of staff partnerships often spans multiple years.
What Success Looks Like After 90 Days
A pharmaceutical CEO with an effectively onboarded chief of staff at the 90-day mark should be experiencing measurable changes in their weekly schedule. The administrative and coordination work that previously consumed 30 to 45 percent of their time should be mostly gone. Their calendar should reflect their actual priorities. Key stakeholder relationships should be receiving consistent attention. The governance and compliance calendar should be tracked proactively.
The cost of building this capability, at $140,000 to $225,000 for an in-house chief of staff, or $10,000 to $19,500 per month for a fractional engagement for a full-time chief of staff, is justified many times over by the strategic leadership value that is created when the pharmaceutical CEO is freed from the operational layer that the chief of staff now owns.
Conclusion
A chief of staff in a pharmaceutical company is a senior strategic support professional whose mandate is to multiply the CEO’s organizational effectiveness through coordination, communication, and execution infrastructure. When properly defined, resourced, and trusted, this role becomes one of the most consequential positions in the pharmaceutical executive team.
Related Reading
For further context, explore What Is a Chief of Staff in Automotive Companies and What Is a Chief of Staff in Construction & Architecture Companies.